共 209 条
- [51] Okita K(1992)Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn’s disease) Blood 79 1763-1767
- [52] Arikawa J(1990)Epstein-Barr virus infection of the colon with inflammatory bowel disease J Virol 64 3033-3041
- [53] Tokunaga M(2002)Inflammatory bowel disease—is there something new in the immunological background? J Virol 76 12543-12552
- [54] Satoh E(2003)Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease Oncogene 22 5122-5130
- [55] Tanaka S(2006)Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease Trans Am Clin Climatol Assoc 117 55-74
- [56] Land CE(2011)Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes Nat Rev Microbiol 9 254-264
- [57] Hungermann D(2012)Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells Curr Opin Gastroenterol 28 63-69
- [58] Muller S(2009)The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F–1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells Ann Clin Lab Sci 39 331-337
- [59] Spieker T(2011)Virally targeted therapies for EBV-associated malignancies J Virol 85 12844-12854
- [60] Lisner R(1809)Woodward award: development of novel, EBV-targeted therapies for EBV-positive tumors Biochim Biophys Acta. 2011 715-721